-
冠心病是以冠状动脉硬化为基础, 以脂质、炎性细胞和结缔组织在动脉壁的沉积为特征的一种慢性渐进性疾病, 其发展缓慢, 初期无任何症状, 多数患者第一次发病时表现为心肌梗死、卒中或心源性死亡。因此早期发现冠状动脉硬化斑块, 尤其是不稳定斑块, 具有重要的临床诊断意义。本研究通过测定并比较冠心病患者与正常对照者血清中细胞因子和超敏C反应蛋白(hypersensitive C-reactive protein, hs-CRP)水平, 探讨其对冠心病的诊断价值及其临床意义。
-
冠心病患者与正常对照者血清细胞因子和hs-CRP水平的检测结果见表 1。与正常对照者比较: 冠心病患者血清中IL-1β、IL-6、IL-8和TNF-α水平明显升高(tIL-1β=3.145, tIL-6=3.627, tIL-8=3.054, tTNF-α=3.301, P均 < 0.01)。其中, SA患者的血清IL-1β、IL-6、IL-8和TNF-α水平与正常对照者比较差异无统计学意义(tIL-1β=1.431, tIL-6=1.587, tIL-8=1.745, tTNF-α=1.461, P均 > 0.05);USA和AMI患者血清IL-1β、IL-6、IL-8和TNF-α水平较正常对照者显著升高(USA: tIL-1β= 2.871, tIL-6=2.748, tIL-8=2.687, tTNF-α=3.145, P均 < 0.01;AMI: tIL-1β=2.776, tIL-6=2.874, tIL-8=2.689, tTNF-α= 3.212, P均 < 0.01);SA、USA和AMI患者血清hs-CRP水平较正常对照者显著升高(tSA=2.617, P < 0.05;tUSA=3.018, P < 0.01;tAMI=3.189, P < 0.01)。
组别 例数 细胞因子 超敏C反应蛋白 白细胞介素1β 白细胞介素6 白细胞介素8 肿瘤坏死因子α 正常对照组 54 2.14 ±1.35 2.38 ±0.68 23.12 ±8.58 1.01 ±0.28 2.21 ±0.48 冠心病组 124 4.45 ±3.34 5.71 ±3.46 45.18 ±26.43 3.18 ±1.42 5.68 ±1.75 SA组 41 2.28 ±1.86 2.61 ± 1.75 25.24 ±10.36 1.18 ±0.42 3.43 ±1.28 USA组 38 5.53 ±3.59 5.34 ±4.06 40.13 ±20.76 2.63 ± 1.75 4.51 ±1.56 AMI组 45 7.08 ± 5.82 8.62 ± 6.37 67.33 ±35.58 5.49 ± 3.01 8.74 ±2.60 注:表中,SA: 稳定型心绞痛;USA: 不稳定型心绞痛;AM丨: 急性心肌梗死。 表 1 冠心病患者和正常对照者血清细胞因子和超敏C反应蛋白水平比较[(x±s)ng/m l]
SA、USA及AMI组间的比较: SA组血清IL-1β、IL-6、IL-8、TNF-α和hs-CRP水平较USA组低(tIL-1β=2.813, tIL-6=2.744, tIL-8=2.712, tTNF-α=2.945, P < 0.01);USA组血清IL-1β、IL-6、IL-8、TNF-α和hs-CRP水平较AMI组低(tIL-1β=2.771, tIL-6=2.814, tIL-8=2.745, tTNF-α=3.145, P < 0.01), 而且随着SA、USA和AMI患者疾病严重程度的增加而升高。
冠心病患者血清细胞因子和超敏C-反应蛋白水平测定的临床意义
Clinical application of changes of serum cytokines and hypersensitive C-reactive protein in patients with coronary heart disease
-
摘要:
目的 探讨冠心病患者血清中细胞因子和超敏C-反应蛋白(hs-CRP)水平的临床意义。 方法 利用放射免疫分析和超敏酶免疫分析法测定124例冠心病患者[其中稳定型心绞痛(SA)41例,不稳定型心绞痛(USA)38例,急性心肌梗死(AMI)45例]血清中白细胞介素1β(IL-1β)、白细胞介素6(IL-6)、白细胞介素8(IL-8)、肿瘤坏死因子α(TNF-α)和hs-CRP水平,并与54名正常对照者进行对比研究。 结果 124例冠心病患者血清IL-1β、IL-6、IL-8和TNF-α水平较54名正常对照者明显升高(tIL-1β=3.145,tIL-6=3.627,tIL-8=3.054,tTNF-α=3.301,P均 < 0.01)。其中,41例SA患者血清IL-1β、IL-6、IL-8和TNF-α水平与54名正常对照者比较差异无统计学意义(tIL-1β=1.431,tIL-6=1.587,tIL-8=1.745,tTNF-α=1.461,P均 > 0.05);38例USA和45例AMI患者血清中IL-1β、IL-6、IL-8和TNF-α水平较54名正常对照者明显升高(USA:tIL-1β=2.871,tIL-6=2.748,tIL-8=2.687,tTNF-α=3.145,P均 < 0.01;AMI:tIL-1β=2.776,tIL-6=2.874,tIL-8=2.689,tTNF-α=3.212,P均 < 0.01);SA、USA和AMI3组患者血清hs-CRP水平较正常对照者升高(tSA=2.617,P < 0.05;tUSA=3.018,P < 0.01;tAMI=3.189,P < 0.01)。冠心病患者血清中IL-1β、IL-6、IL-8、TNF-α和hs-CRP水平随疾病的严重程度而逐渐升高,以AMI患者为最高。 结论 血清IL-1β、IL-6、IL-8、TNF-α和hs-CRP水平的测定是诊断SA、USA和AMI疾病的重要指标,并可作为诊断心血管事件发生的参考。 Abstract:Objective To study clinical application of the changes of serum cytokines andhypersensitive C. reactive protein(hs, CRP)in patients with coronary heart disease. Methods The levels of interleukin-1β(IL-1β), interleukin-6(IL-6), interleukin-8(IL-8), hs-CRP(with high-sensitive enzyme immunoassay) and tumor necrosis factor α(TNF-α)(with radioimmunoassay)in blood serum were determined in 124 patients with coronary heart disease(including 41 patients with stable angina pectoris (SA), 38 patients with unstable angina(USA)and 45 patients with acute myocardial infarction(AMI))and 54 normal controls, and then comparatively analysed all the data. Results The levels of IL-1β, IL-6, IL-8 and TNF-α in 124 patients with coronary heart disease were significantly higher than those in 54 normal controls(tIL-1β=3.145, tIL-6=3.627, tIL-8= 3.054, tTNF-α=3.301, P < 0.01).The levels of IL-1β, IL-6, IL-8 and TNF-α in 41 patients with SA were no significantly than those in 54 normal controls(tIL-1β=1.431, tIL-6=1.587, tIL-8=1.745, tTNF-α=1.461, P > 0.05).The levels of IL-1β, IL-6, IL-8 and TNF-α in 38 patients with USA and in 45 patients with AMI were significantly higher than those of in 54 normal controls(USA: tIL-1β=2.871, tIL-6=2.748, tIL-8=2.687, tTNF-α=3.145, P < 0.01; AMI: tIL-1β=2.776, tIL-6=2.874, tIL-8=2.689, tTNF-α=3.212, P < 0.01).The level of hs-CRP in SA, USA and AMI groups were higher than thoes in normal controls(tSA=2.617, P < 0.05; tUSA=3.018, P < 0.01; tAMI=3.189, P < 0.01).The levels of IL-1β, IL-6, IL-8, TNF-α and hs-CRP had increasing tendency follow up the severity degree of patients with SA or USA or AMI and the levels of IL-1β, IL-6, IL-8, TNF-α and hs-CRP in patients with AMI were highest in 124 patients with coronary heart disease. Conclusion In the diagnosis of the patients with SA, USA and AMI, the determination of the levels of IL-1β, IL-6, IL-8, TNF-α and hs-CRP in blood serum were important index, and they were references for cardiovascular happened. -
Key words:
- Coronary disease /
- Cytokines /
- Tumor necrosis factor-alpha /
- C-reactive protein /
- Radioimmuno assay
-
表 1 冠心病患者和正常对照者血清细胞因子和超敏C反应蛋白水平比较[(x±s)ng/m l]
组别 例数 细胞因子 超敏C反应蛋白 白细胞介素1β 白细胞介素6 白细胞介素8 肿瘤坏死因子α 正常对照组 54 2.14 ±1.35 2.38 ±0.68 23.12 ±8.58 1.01 ±0.28 2.21 ±0.48 冠心病组 124 4.45 ±3.34 5.71 ±3.46 45.18 ±26.43 3.18 ±1.42 5.68 ±1.75 SA组 41 2.28 ±1.86 2.61 ± 1.75 25.24 ±10.36 1.18 ±0.42 3.43 ±1.28 USA组 38 5.53 ±3.59 5.34 ±4.06 40.13 ±20.76 2.63 ± 1.75 4.51 ±1.56 AMI组 45 7.08 ± 5.82 8.62 ± 6.37 67.33 ±35.58 5.49 ± 3.01 8.74 ±2.60 注:表中,SA: 稳定型心绞痛;USA: 不稳定型心绞痛;AM丨: 急性心肌梗死。 -
[1] Simon AD, Yazdani S, Wang W, et al. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolysis, 2000, 9(3): 217-222. doi: 10.1023/A:1018758409934 [2] Pang G, Ortega M, Zighang R, et al. Autocrine modulation of IL-8 production by sputum neutrophils in chronic bronchial sepsis. Am J Respir Crit Care Med, 1997, 155(2): 726-731. [3] März W, Wieland H. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?. Herz, 2000, 25(2): 117-125. doi: 10.1007/PL00001949 [4] Aukrust P, Berge RK, Ueland T, et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol, 2001, 37(2): 485-491. doi: 10.1016/S0735-1097(00)01110-4 [5] Saadeddin SM, Habbab MA, Ferns GA. Markers of inflammation and coronary artery disease. Med Sci Monit, 2002, 8(1): RA5-RA12. [6] Retterstol L, Eikvar L, Berg K. A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease. Atherosclerosis, 2003, 169(2): 279-282. doi: 10.1016/S0021-9150(03)00192-8 [7] Ridker PM, RifaiN, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002, 347(20): 1557-1565. doi: 10.1056/NEJMoa021993 [8] 中华医学会检验分会, 卫生部全国临床检验标准委员会临床应用准则专家委员会, 卫生部临床检验中心, 等. 冠状动脉疾病和心力衰竭时心脏标志物临床检测应用建议. 中华检验学杂志, 2006, 29(9): 774-778.